Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,414 | -16,461 | -24,907 | -39,204 | -27,471 |
| Depreciation Amortization | 494 | 860 | 1,371 | 1,567 | 725 |
| Accounts receivable | -36 | 19 | 23 | -2 | -42 |
| Other Working Capital | 1,092 | 253 | -3,126 | 1,088 | -138 |
| Other Operating Activity | 1,596 | 2,130 | 3,357 | 5,510 | 4,807 |
| Operating Cash Flow | $-13,268 | $-13,199 | $-23,281 | $-31,040 | $-22,119 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 0 | 24,062 | -24,010 | N/A |
| PPE Investments | -68 | 23 | -100 | -824 | -2,234 |
| Investing Cash Flow | $-68 | $23 | $23,962 | $-24,834 | $-2,234 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 792 | 1,086 |
| Debt Issued | N/A | N/A | N/A | 7,805 | 0 |
| Debt Repayment | N/A | N/A | -15,000 | -8,896 | 0 |
| Common Stock Issued | 12,117 | 13,392 | 11,727 | 2,732 | 63,466 |
| Other Financing Activity | -40 | 3,011 | -3,105 | -132 | 0 |
| Financing Cash Flow | $12,077 | $16,404 | $-6,378 | $2,301 | $64,552 |
| Exchange Rate Effect | N/A | N/A | 8 | -6 | 0 |
| Beginning Cash Position | 11,453 | 8,226 | 13,915 | 67,493 | 27,294 |
| End Cash Position | 10,195 | 11,453 | 8,226 | 13,915 | 67,493 |
| Net Cash Flow | $-1,258 | $3,227 | $-5,689 | $-53,578 | $40,199 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,268 | -13,199 | -23,281 | -31,040 | -22,119 |
| Capital Expenditure | -68 | -5 | -101 | -824 | -2,241 |
| Free Cash Flow | -13,335 | -13,204 | -23,382 | -31,863 | -24,360 |